Silencing LINC02418 decreased CRC cell proliferation, whereas transfection of BCL2 or a miR-34b-5p inhibitor into LINC02418-silenced CRC cells enhanced cell growth significantly [21]. This evidence concerns the gene BCL2 and colorectal carcinoma.